Correlation between six-minute walk test and pulmonary function test in COPD patients with exacerbations: a preliminary report
äºComparative Exercise PhysiologySearch for other papers by P. Rana in
Current site
Google Scholar
Search for other papers by S. Chatterjee in
Current site
Google Scholar
Abstract
Introduction: Exacerbations of chronic obstructive pulmonary disease (ECOPD) frequently occur in primary care, but diagnosing them accurately and promptly can be challenging. Six-minute walk test is a cost-effective and well-documented field test used to assess aerobic capacity, response to medical treatments in cardiopulmonary diseases, and predict cardiorespiratory fitness. This study aims to explore the relationship between the six-minute walk test and pulmonary function variables in COPD patients with exacerbations. Methods: From January to November 2024, 46 consecutive COPD patients with a history of exacerbations were included from a tertiary care hospital. Patients had a post-bronchodilator FEV1/FVC ratio < 0.7, and 6MWD were conducted per ATS guidelines. Percent predicted 6MWD was calculated, and the correlation between spirometry and 6MWT was analyzed. The study was approved by the Institutional Ethical Committee (MMDU/IEC/2700). Results: Pearsonâs correlation coefficient (r) determined a moderate positive correlation (r = 0.510) between the six-minute walk test and FEV1/FVC in COPD patients with exacerbations. Conclusion: The findings of our study indicate a moderate positive correlation between the 6MWT and the spirometry variable (FEV1/FVC) in COPD patients experiencing exacerbations. These results may have clinical significance in assessing disease prognosis and estimating aerobic capacity (VO2max) in COPD patients during exacerbations.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
ATS, 2002. American Thoracic Society ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 166: 111-177.
-
Carvalho Jr, L.C.S., Trimer, R., AreÌas, G.P.T., Caruso, F.C.R., Zangrando, K.T.L., Jürgensen, S.P., Bonjorno Jr, J.C., de Oliveira, C.R., Cabiddu, R., Mendes, R.G. and Borghi-Silva, A., 2018. COPD assessment test and FEV 1: do they predict oxygen uptake in COPD? International Journal of Chronic Obstructive Pulmonary Disease 13: 3149-3156.
-
CavailleÌs, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.C., Morel, H., Person-Tacnet, C., Leroyer, C. and Diot, P., 2013. Comorbidities of COPD. European Respiratory Review 22(130): 454-475.
-
Chen, H., Liang, B.M., Tang, Y.J., Xu, Z.B., Wang, K., Yi, Q., Ou, X.M. and Feng, Y.L., 2012. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities. Chinese Medical Journal 125(17): 3053-3058.
-
Claxton, S., Porter, P., Brisbane, J., Bear, N., Wood, J., Peltonen, V., Della, P., Smith, C. and Abeyratne, U., 2021. Identifying acute exacerbations of chronic obstructive pulmonary disease using patient-reported symptoms and cough feature analysis. npj Digital Medicine 4(1): 107. http://dx.doi.org/10.1038/s41746-021-00472-x
-
GOLD guideline, 2023. Global initiative for chronic obstructive lung. A Guide for Health Care Professionals 1(3): 261-266.
-
Krishna, B.S., Mohapatra, A.K., Behera, D., Jagaty, S.K., Subhankar, S., Venkataram, R. and Dash, D.P., 2022. Six-minute walk test and its correlation with spirometry in stable COPD patients. Journal of Health and Allied Sciences NU 12(03): 280-285.
-
Lareau, S., Moseson, E. and Slatore, C.G., 2018. Exacerbation of COPD. American Journal of Respiratory and Critical Care Medicine 198(11): 21-22.
-
Machado, F.V.C., Bisca, G.W., Morita, A.A., Rodrigues, A., Probst, V.S., Furlanetto, K.C., Pitta, F. and Hernandes, N.A., 2018. Agreement of different reference equations to classify patients with COPD as having reduced or preserved 6MWD. Pulmonology 24(1): 16-22. http://dx.doi.org/10.1016/j.rppnen.2017.08.007
-
Mathur, R. and Swaminathan, S., 2018. National ethical guidelines for biomedical & health research involving human participants, 2017: a commentary. Indian Journal of Medical Research 148(3): 279-283.
-
Meghashri, V., Raveesha, A., Guruprasad, Mehta, C. and Deepthi, M., 2023. Correlation of six minute walking test, sit to stand test and pulmonary function test in patients with chronic obstructive pulmonary disease. Journal of Clinical and Diagnostic Research: 10-13.
-
Minov, J., Karadzinska-Bislimovska, J., Vasilevska, K., Stoleski, S. and Mijakoski, D., 2015. Course of COPD Assessment Test (CAT) scores during bacterial exacerbations of chronic obstructive pulmonary disease treated in outpatient setting. The Open Respiratory Medicine Journal 9.
-
Portney, L.G. and Watkins, M.P., 2012. Foundation clinical research. Foreign Affairs Journal 91(5): 390-404, 503-522.
-
Raherison, C. and Girodet, P.O., 2009. Epidemiology of COPD. European Respiratory Review 18(114): 213-221.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 188 | 188 | 5 |
| å ¨ææµè§æ¬¡æ° | 9 | 9 | 0 |
| PDFä¸è½½æ¬¡æ° | 113 | 113 | 0 |
Correlation between six-minute walk test and pulmonary function test in COPD patients with exacerbations: a preliminary report
äºComparative Exercise PhysiologySearch for other papers by P. Rana in
Current site
Google Scholar
PubMed
Search for other papers by S. Chatterjee in
Current site
Google Scholar
PubMed
Abstract
Introduction: Exacerbations of chronic obstructive pulmonary disease (ECOPD) frequently occur in primary care, but diagnosing them accurately and promptly can be challenging. Six-minute walk test is a cost-effective and well-documented field test used to assess aerobic capacity, response to medical treatments in cardiopulmonary diseases, and predict cardiorespiratory fitness. This study aims to explore the relationship between the six-minute walk test and pulmonary function variables in COPD patients with exacerbations. Methods: From January to November 2024, 46 consecutive COPD patients with a history of exacerbations were included from a tertiary care hospital. Patients had a post-bronchodilator FEV1/FVC ratio < 0.7, and 6MWD were conducted per ATS guidelines. Percent predicted 6MWD was calculated, and the correlation between spirometry and 6MWT was analyzed. The study was approved by the Institutional Ethical Committee (MMDU/IEC/2700). Results: Pearsonâs correlation coefficient (r) determined a moderate positive correlation (r = 0.510) between the six-minute walk test and FEV1/FVC in COPD patients with exacerbations. Conclusion: The findings of our study indicate a moderate positive correlation between the 6MWT and the spirometry variable (FEV1/FVC) in COPD patients experiencing exacerbations. These results may have clinical significance in assessing disease prognosis and estimating aerobic capacity (VO2max) in COPD patients during exacerbations.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 188 | 188 | 5 |
| å ¨ææµè§æ¬¡æ° | 9 | 9 | 0 |
| PDFä¸è½½æ¬¡æ° | 113 | 113 | 0 |
